Reviewing INVO Fertility (NASDAQ:IVF) & Presbia (OTCMKTS:LENSF)

Presbia (OTCMKTS:LENSF) and INVO Fertility (NASDAQ:IVF) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations and institutional ownership.

Profitability

This table compares Presbia and INVO Fertility’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Presbia	N/A	N/A	N/A
INVO Fertility	-417.02%	N/A	-92.42%

Earnings & Valuation

This table compares Presbia and INVO Fertility”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Presbia	N/A	N/A	N/A	N/A	N/A
INVO Fertility	$6.53 million	0.71	-$9.10 million	($630.29)	0.00

Presbia has higher earnings, but lower revenue than INVO Fertility.

Risk and Volatility

Presbia has a beta of 5.91, indicating that its stock price is 491% more volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.66, indicating that its stock price is 166% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent recommendations for Presbia and INVO Fertility, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Presbia	0	0	0	0	0.00
INVO Fertility	1	0	0	1	2.50

INVO Fertility has a consensus target price of $4.00, suggesting a potential upside of 497.01%. Given INVO Fertility’s stronger consensus rating and higher probable upside, analysts plainly believe INVO Fertility is more favorable than Presbia.

Insider and Institutional Ownership

12.0% of INVO Fertility shares are held by institutional investors. 74.2% of Presbia shares are held by company insiders. Comparatively, 0.7% of INVO Fertility shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

INVO Fertility beats Presbia on 5 of the 9 factors compared between the two stocks.

About Presbia

Presbia PLC, an ophthalmic device company, develops and markets optical lens implants for treating presbyopia. The company provides the refractive lens for patient surgeries, as well as accessories for procedures. It primarily operates in the United States, South Korea, Australia, Italy, the Netherlands, Ireland, Canada, and Germany. The company was founded in 2014 and is headquartered in Dublin, Ireland.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.